Li Ling Tan
- Cardiology and Cardiovascular Medicine top 10%
- Oncology
- Molecular Biology
- Pulmonary and Respiratory Medicine
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- Mit ShahRajdeep KhattarRakesh SharmaAlexander R. LyonA. John BaksiPedro MolinerNilesh PareekStuart D. Rosen
- Topics
- Chemotherapy-induced cardiotoxicity and mitigation (9 papers)Heart Failure Treatment and Management (7 papers)Cardiac Imaging and Diagnostics (3 papers)
- Partner nations
- SingaporeChinaNew Zealand
In The Last Decade
Li Ling Tan
24 papers receiving 275 citations
Peers
Comparison fields: 5 of 70
- Cardiology and Cardiovascular Medicine 149
- Oncology 52
- Molecular Biology 39
- Pulmonary and Respiratory Medicine 38
- Radiology, Nuclear Medicine and Imaging 37
Countries citing papers authored by Li Ling Tan
This map shows the geographic impact of Li Ling Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Ling Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Ling Tan more than expected).
Fields of papers citing papers by Li Ling Tan
This network shows the impact of papers produced by Li Ling Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Ling Tan. The network helps show where Li Ling Tan may publish in the future.
Co-authorship network of co-authors of Li Ling Tan
This figure shows the co-authorship network connecting the top 25 collaborators of Li Ling Tan. A scholar is included among the top collaborators of Li Ling Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Ling Tan. Li Ling Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 4 | |
| 6 | 17 | |
| 7 | 15 | |
| 8 | 5 | |
| 9 | 21 | |
| 10 | 1 | |
| 11 | 4 | |
| 12 | 5 | |
| 13 | 1 | |
| 14 | 17 | |
| 15 | 12 | |
| 16 | 94 | |
| 17 | 29 | |
| 18 | Expression of protein TARBP1 in human hepatocellular carcinoma and its prognostic significance. | 7 |
| 19 | 1 | |
| 20 | 5 |
About Li Ling Tan
Li Ling Tan is a scholar working on Cardiology and Cardiovascular Medicine, Otorhinolaryngology and Family Practice, having authored 27 papers that have together received 280 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (9 papers), Heart Failure Treatment and Management (7 papers) and Cardiac Imaging and Diagnostics (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (149 citations), Family Practice (10 citations) and Oncology (52 citations). Li Ling Tan has collaborated with scholars based in Singapore, China and New Zealand. Frequent co-authors include Mit Shah, Rajdeep Khattar, Rakesh Sharma, Alexander R. Lyon, A. John Baksi, Pedro Moliner, Nilesh Pareek, Stuart D. Rosen, Jinlin Guo and Cai‐Xia Yang. Their work appears in journals such as Scientific Reports, European Heart Journal and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.